Core Viewpoint - Primo Brands Corporation has appointed Eric Foss as the new Chairman and CEO, succeeding Robbert Rietbroek, to lead the company through its next growth phase in the healthy hydration market [1][3][4]. Company Leadership - Eric Foss brings extensive experience as a former Chairman and CEO of global consumer-centric businesses, known for his people-first leadership and brand-building expertise [2][3]. - Dean Metropoulos, the former Non-Executive Chairman, expressed confidence in Foss's ability to drive progress at Primo Brands and will continue to serve on the Board as a Director [4]. Company Positioning - Foss highlighted that Primo Brands is well-positioned in the growing healthy hydration market, with a strong brand portfolio and a robust go-to-market system [3]. - The company aims to unlock the potential of its recent business combination and has identified multiple growth vectors moving forward [3]. Company Overview - Primo Brands is a leading North American branded beverage company focused on healthy hydration, with a diverse portfolio that includes well-known brands such as Poland Spring® and Pure Life® [6]. - The company operates a vertically integrated distribution network, reaching over 200,000 retail outlets and offering direct delivery services to homes and businesses [6][7]. - Primo Brands is committed to sustainability, utilizing reusable packaging and managing water resources responsibly [7].

Company Leadership Transition - Assertio Holdings, Inc. has appointed Mark L. Reisenauer as the new CEO, effective immediately, succeeding Brendan P. O'Grady [1][2] - The Board of Directors believes Reisenauer is well-suited to lead the company into its next growth phase, focusing on enhancing efficiency and delivering long-term value [2] Upcoming Financial Results - Assertio will release its third quarter 2025 financial results on November 10, 2025, after market close [3] - A live webcast conference call will be held at 4:30 p.m. Eastern Time on the same day to discuss the financial results and provide updates on the company's strategic plans for 2025 [3] Mark Reisenauer's Background - Mark Reisenauer has over 30 years of experience in the oncology space, previously serving as President of U.S. Commercial at Astellas Pharmaceuticals, where he grew sales to nearly $5 billion [5] - He has a strong track record in building and launching franchises and products, making him highly qualified for the CEO role at Assertio [2][5] Company Overview - Assertio is a pharmaceutical company focused on marketing differentiated products in oncology, neurology, and pain management [6][7]

Core Viewpoint - Derrick Duke has been appointed as the new Chief Executive Officer of eHealth, Inc., succeeding Fran Soistman, who will retire but remain on the Board of Directors and assist during the transition period [1][4][5]. Group 1: Leadership Transition - Derrick Duke will officially assume the CEO role on September 18, 2025, after starting the transition on August 4, 2025 [1]. - Fran Soistman will continue to serve as an executive advisor until December 31, 2025, to support the transition [1]. Group 2: Derrick Duke's Background - Derrick Duke has over 30 years of strategic leadership and financial expertise in the health insurance and managed care sectors [6]. - He previously served as CEO of Magellan Health, where he led significant operational and financial initiatives [2][6]. - Duke has held various senior roles at HealthMarkets, including Chief Investment Officer and Chief Financial Officer, and played a key role in its acquisition by UnitedHealth Group in 2019 [7]. Group 3: Board and Company Statements - Beth Brooke, Chair of eHealth's Board, expressed confidence in Duke's ability to lead eHealth into a new phase of profitable growth, highlighting his operational expertise and financial acumen [3]. - Fran Soistman acknowledged the accomplishments during his tenure and expressed confidence in Duke's leadership for eHealth's future [4][5].